We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current N1VS34 market cap is 102.61B. The company's latest EPS is USD 7.2670 and P/E is 13.35.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 13.97B | 12.95B | 14.19B | 6.87B | 20.09B |
| Operating Income | 1.95B | 2.86B | 2.92B | 1.41B | 2.84B |
| Net Income | 1.47B | 2.29B | 2.32B | 1.76B | 8.48B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 50.49B | 49.9B | 52.88B | 51.83B | 54.11B |
| Operating Income | 9.82B | 10.83B | 27.03B | 9.19B | 10.02B |
| Net Income | 11.73B | 8.07B | 24.02B | 6.96B | 14.85B |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 117.45B | 112.24B | 110.98B | 112.7B | 99.95B |
| Total Liabilities | 58.03B | 60.1B | 59.05B | 74.45B | 53.2B |
| Total Equity | 59.42B | 52.14B | 51.93B | 38.25B | 46.75B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 118.37B | 132.06B | 131.8B | 117.45B | 99.95B |
| Total Liabilities | 62.82B | 75.39B | 63.97B | 58.03B | 53.2B |
| Total Equity | 55.55B | 56.67B | 67.82B | 59.42B | 46.75B |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 14.24B | 2.96B | 6.53B | 11.91B | 9.84B |
| Investing | 1.47B | 10.62B | 9.57B | 7.36B | N/A |
| Financing | -20.56B | -9.2B | -12.84B | -13.67B | N/A |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 13.63B | 13.65B | 15.07B | 14.24B | 9.84B |
| Investing | -2.23B | -13.18B | 4.21B | 1.47B | N/A |
| Financing | -13.63B | -2.21B | -16.26B | -20.56B | N/A |
| Market Cap | 102.61B |
| Price to Earnings Ratio | 13.35 |
| Price to Sales Ratio | 3.66 |
| Price to Cash Ratio | 14.8 |
| Price to Book Ratio | 4.24 |
| Dividend Yield | - |
| Shares Outstanding | 2.04B |
| Average Volume (1 week) | 87 |
| Average Volume (1 Month) | 32 |
| 52 Week Change | -3.83% |
| 52 Week High | 54.20 |
| 52 Week Low | 45.60 |
| Spread (Intraday) | 3.24 (6.09%) |
| Company Name | Novartis AG |
| Address |
po box basel 4002 |
| Website | https://www.novartis.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
